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Serum Transaminase 
An Aid To Diagnosis 
Gerald J. Crawley, B.S.* 
T he purpose of this report is to present 
a background to the understanding of 
transaminase reaction and its possible im-
portance as a diagnostic aid in certain 
pathological conditions to the student of 
veterinary medicine. In a short treatise 
of this type, it is not possible to go into 
the complex mechanisms of the reaction, 
but it is intended to outline a few of the 
general principles with which the veter-
inarian should be familiar. For the most 
part contact with this subject has been 
limited to a very brief explanation in bio-
chemistry and physiology, plus informa-
tion which can be gained from the hos-
pital clinicians during clinic hours. 
Enzymatic transamination consists of 
the enzyme catalyzed reversible transfer of 
the a-amino nitrogen of an amino acid to 
an a-keto acid with the synthesis of a sec-
ond amino acid and a second a-keto acid. 
Braunstein and Kritzman (2) first demon-
strated the presence of enzymes catalyz-
ing such reactions in pigeon breast and 
rabbit muscle in 1937. Subsequent studies 
have revealed that transamination is prob-
ably the most important metabolic mech-
anism in both the formation and deamin-
ation of many amino acids in various tis-
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sues. Under normal conditions these en-
zymes are confined almost entirely within 
the tissue cells although a very small 
amount is normally found in the blood 
serum. It is believed that during necrosis 
of these cells the enzyme is liberated into 
the circulation and can be a measure of 
the amount of tissue necrosis (10). The 
two transaminases found most active in 
animal tissues are glutamic oxalacetic and 
glutamic pyruvic transaminase. ' 
Many methods have been devised to 
measure the level of transaminase in the 
serum. To date, the most practical of these 
methods is by using the spectrophotometer 
or the colorimeter. At the present time 
there are a number of clinical methods 
available and are being used routinely in 
human medicine (3, 12) and can be 
adapted to use by the veterinarian. 
The tissues which contain the largest 
amount of these transaminases are heart 
muscle, skeletal muscle, liver, and the 
central nervous system. The latter re-
leases its enzymes into the spinal fluid 
and they can not be demonstrated in blood 
serum. Other organs also contain trans-
aminases, but in lesser amounts ( 13). 
Thus, it can readily be seen that although 
increased levels in the serum indicate a 
diseased state or damaged tissue, the 
source of this increase can not be specific-
ally determined. Therefore, it is absolutely 
necessary that the entire clinical picture 
be evaluated carefully, using serum tran-
saminase levels as another clinical aid. 
Although much of the preliminary work 
was accomplished with the aid of animals, 
there is very little information available 
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which can be used on a clinical level and 
most standards for animals now used have 
been adapted from those found in the hu-
man. However, it is known there are many 
species' variabilities and there is a con-
siderable amount of work at present to de-
termine in which animals this reaction 
can be used for diagnostic purposes and 
within what range of values these levels 
can be considered normal, mildly abnor-
mal and very serious (5, 6). Because the 
dog· was used most often in experimental 
work, normal values have been tentatively 
established for this species and this test is 
being used in a few laboratories as an ad-
junct to diagnosis of cardiac and liver 
pathology. 
Generally speaking, the two main en-
zymes of interest at the present are serum 
glutamic oxalacetic transaminase (SGOT) 
and serum glutamic pyruvic transaminase 
(SGPT). However, the latest work indi-
cates that other enzymes may be just as, 
or even more valuable, as diagnostic acids; 
notable among these is lactic dehydrogen-
ase (LDH) (7). The normal levels of 
SGOT and SGPT have been established as 
15-35 and 10-30 Karman units respective-
ly. However, there is much variation 
among individuals. The maximum serum 
concentration is reached 16-28 hours fol-
lowing myocardial tissue damage and is 
usually completely gone within 4 days. 
Although both are considerably elevated 
in myocardial damage, the SGOT is much 
more elevated - sometimes as high as 30 
times the normal values. Both are also 
elevated in liver necrosis, but in this case 
the SGPT rises conSiderably higher than 
it would in myocardial problems and the 
time-concentration· curve is conSiderably 
changed (8, 11). It should be emphasized 
that an elevated concentration of serum 
transaminase during hepatic disease re-
flects actual parenchymal injury and is not 
a liver function test. But when used in 
conjunction with liver function tests and 
symptoms, transaminase determinations 
can be a great aid in establishing a diag-
nosis as well as a prognosis. 
The determination of the levels of activ-
ity of various enzymes in the blood or 
serum of animals represents a major ad-
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vance in the laboratory diagnosis of vari-
ous disease conditions. Clinical methods 
are available at a small cost which re-
quire little, if any, extra equipment than 
is already present in the normally equipped 
laboratory. It must be repeated that the 
results of these tests cannot be considered 
as a specific diagnosis, but when consid-
ered in light of other clinical symptoms 
and tests, can be a valuable aid in diag-
nosis and prognosis. Any cause of tissue 
breakdown - trauma, infection, infarc-
tion, ischemia, neoplasia, and perhaps 
even nutritional deficiencies (white muscle 
disease (1) ) may result in elevated serum 
levels, presumably by the release of en-
zymes from the damaged tissue. Despite 
this limitation, serum transaminase de-
terminations serve, in the proper clinical 
setting, as a highly valuable indicator of 
myocardial and liver necrosis. It aids espe-
cially in the early diagnosis which is so 
often essential if treatment is to be bene-
ficial; failure to observe serum elevations 
on serial testing is an important negative 
finding. 
As our knowledge of disease conditions 
continue to increase so must our methods 
by which these conditions are diagnosed. 
Many of the problems that faced the vet-
erinarian of yesteryear have been resolved 
in a relatively short period of time during 
the past few years. The diagnosis of many 
of the poorly understood conditions of to-
day may well be resolved by the use of 
transaminase tests. Even many of the 
conditions which are well understood, but 
in which accurate diagnosis is difficult 
with the methods now available, may be-
come routinely diagnosed by transaminase 
studies. It is hoped that transaminase re-
actions may be the key to opening some of 
the hidden secrets of the central nervous 
system and the reasons for certain toxicity 
symptoms. 
It appears that although transaminases 
may be a valuable adjunct to large animal 
disease diagnosis, their principal use will 
be in the realm of the small animal clin-
ician. Small animal pets nowadays are re-
ceiving increasingly better care. This leads 
to greater longevity. The treatment of geri-
atric problems by the small animal clini-
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cian has become an important phase of 
practice, and this phase will continue to 
grow (4). Many of these problems are 
centered around cardiac and liver path-
ology and the means now available for 
diagnosing these abnormalities in dogs 
often fail to give unequivocal information. 
Therefore, treatment is often based on in-
tuition and past experience with no guar-
antee that the treatment is specific for the 
condition presented. By the use of tran-
saminase determinations many of these 
inabilities on the part of the clinician may 
be alleviated. 
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